Cost-effectiveness of pharmacogenomic-guided treatment for major depression

202342 citationsJournal Articlegold Open Access

Authors

Shahzad Ghanbarian · Vancouver Coastal Health

Gavin Wong · Vancouver Coastal Health

Mary Bunka · Vancouver Coastal Health

Louisa Edwards · Vancouver Coastal Health

Sonya Cressman · Vancouver Coastal Health

Tania Conte · Vancouver Coastal Health

Morgan Price ·

Abstract

Pharmacogenomic testing to guide antidepressant use was estimated to yield population health gains while substantially reducing health system costs. These findings suggest that pharmacogenomic testing offers health systems an opportunity for a major value-promoting investment.

Topics & Keywords

Treatment of Major Depression Tryptophan and brain disorders Pharmacogenetics and Drug Metabolism

Publication Details

Published in: Canadian Medical Association Journal

Volume 195, Issue 44, pp. E1499-E1508

DOI: 10.1503/cmaj.221785

Field-Weighted Citation Impact: 10.13

Command Palette

Cost-effectiveness of pharmacogenomic-guided treatment for major depression

Authors

Abstract

Topics & Keywords

Publication Details